- Home
- GGT vs ALEC Comparison
GGT vs ALEC Comparison
Compare GGT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- ALEC
- Stock Information
- Founded
- GGT 1994
- ALEC 2013
- Country
- GGT United States
- ALEC United States
- Employees
- GGT N/A
- ALEC N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GGT Finance
- ALEC Health Care
- Exchange
- GGT Nasdaq
- ALEC Nasdaq
- Market Cap
- GGT 152.3M
- ALEC 124.0M
- IPO Year
- GGT N/A
- ALEC 2019
- Fundamental
- Price
- GGT $4.24
- ALEC $3.08
- Analyst Decision
- GGT
- ALEC Buy
- Analyst Count
- GGT 0
- ALEC 7
- Target Price
- GGT N/A
- ALEC $4.50
- AVG Volume (30 Days)
- GGT 59.7K
- ALEC 1.3M
- Earning Date
- GGT 01-01-0001
- ALEC 11-05-2025
- Dividend Yield
- GGT 15.56%
- ALEC N/A
- EPS Growth
- GGT N/A
- ALEC N/A
- EPS
- GGT 0.83
- ALEC N/A
- Revenue
- GGT N/A
- ALEC $81,130,000.00
- Revenue This Year
- GGT N/A
- ALEC N/A
- Revenue Next Year
- GGT N/A
- ALEC $290.50
- P/E Ratio
- GGT $6.90
- ALEC N/A
- Revenue Growth
- GGT N/A
- ALEC 46.77
- 52 Week Low
- GGT $4.32
- ALEC $0.87
- 52 Week High
- GGT $7.00
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- GGT 49.95
- ALEC 57.52
- Support Level
- GGT $4.22
- ALEC $3.04
- Resistance Level
- GGT $4.31
- ALEC $3.33
- Average True Range (ATR)
- GGT 0.04
- ALEC 0.20
- MACD
- GGT -0.00
- ALEC -0.03
- Stochastic Oscillator
- GGT 29.58
- ALEC 63.00
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.